Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03732742
Other study ID # TOF repair
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 2018
Est. completion date September 2019

Study information

Verified date November 2018
Source Assiut University
Contact Shareef Al Shareef, Master
Phone +966533505988
Email shareefaldesoky12@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare of mid-term results of total correction of tetralogy of fallot between preservation of pulmonary valve and trans-annular patching , thus avoiding PV regurgitation during TOF repair , this will determine the value of this procedure over trans-annular patching regarding to right ventricular performance.


Description:

Surgical repair of congenital lesions associated with right ventricular outflow tract obstruction frequently requires the destruction of pulmonary valve (PV) competents including the pulmonary annulas. The resulatnt pulmonary insufficiency may lead to late functional deterioration of right ventricular performance. Acute right ventricular dysfunction has been associated with poor pulmonary runoff, tricuspid valve regurgitaion and pulmonary hypertension. Preservation of PV comptence may prevent both early and late right ventricular failure. Total repair of tetralogy of fallot is a corrective surgical procedure that involves closure of the ventricular septal defect (VSD) and relief of right ventricular outflow tract (RVOT) obstruction. The surgeon must decide whether the right ventricular outflow tract size will be sufficient to allow for the entire cardiac output to traverse it without causing extreme elevation in right ventricular pressure or will go for trans-annular patch. Recently interest has shifted to preserving the integrity of the pulmonary valve annulus thus avoiding pulmonary valve regurgitation.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date September 2019
Est. primary completion date August 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

1. Patients undergoing elective total correction of tetralogy of Fallot.

2. Any age group.

3. Normal pulmonay branches

Exclusion Criteria:

1. Patients associated with other congenital anomalies.

2. Regarding PV morphology, patients with pulmonary atresia , absence of PV.

3. Patients with anomalous coronary artery anatomy obstructs access to the RV

4. Extra-cardiac illness that is expected to limit survival to less than 5 years.e.g active hepatitis or significant hepatic or renal disorders.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
TOF repair with trans-annular patch VS preservation of PV
One group study

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (2)

Kwak JG, Kim WH, Kim ER, Lim JH, Min J. One-Year Follow-up After Tetralogy of Fallot Total Repair Preserving Pulmonary Valve and Avoiding Right Ventriculotomy. Circ J. 2018 Oct 5. doi: 10.1253/circj.CJ-18-0690. [Epub ahead of print] — View Citation

Vida VL, Angelini A, Guariento A, Frescura C, Fedrigo M, Padalino M, Sanders SP, Thiene G, Stellin G. Preserving the pulmonary valve during early repair of tetralogy of Fallot: Anatomic substrates and surgical strategies. J Thorac Cardiovasc Surg. 2015 May;149(5):1358-63.e1. doi: 10.1016/j.jtcvs.2015.01.030. Epub 2015 Jan 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Gender Parameters will be measured include gender in follow up after 6 months. Reassessment after 6 months.
Other Body weight Parameters will be measured include body weight in kilograms in follow up after 6 months. Reassessment after 6 months.
Other Height Parameters will be measured include body height in meters in follow up after 6 months. Reassessment after 6 months.
Other Oxygen saturation , RV function Parameters will be measured include Oxygen saturation level % , RV function by measure RV fractional area changes (RVFAC) % in follow up after 6 months. Reassessment after 6 months.
Other include median RVOT gradient and degree of PV stenosis Parameters will be measured include include median RVOT gradient in mmhg and degree of PV stenosis by peak gradient across the PV in mmhg in follow up after 6 months. Reassessment after 6 months.
Other PV annulus and PV z-score Parameters will be measured include median PV annulus diameter in mm , median PV Z-score diameter in mm in follow up after 6 months. Reassessment after 6 months.
Other degree of PV regurge, degree of TR and RV size Parameters will be measured include degree of PV regurge jet size by color doppler,degree of TR by jet area -central jets in cm^2 , RV size (RV diastolic area in cm^ , RV systolic area in cm^ ) in follow up after 6 months. Reassessment after 6 months.
Other Age Parameters will be measured include age in months in follow up after 6 months. Reassessment after 6 months.
Primary Gender Parameters will be measured include gender preoperatively One week for preoperative assessment.
Primary Body weight Parameters will be measured include body weight in kilograms preoperatively One week for preoperative assessment.
Primary Height Parameters will be measured include height in meters preoperatively One week for preoperative assessment.
Primary Oxygen saturation , RV function Parameters will be measured include Oxygen saturation level % , RV function by measure RV fractional area changes (RVFAC) % preoperatively One week for preoperative assessment.
Primary include median RVOT gradient and degree of PV stenosis Parameters will be measured include median RVOT gradient in mmhg , degree of PV stenosis by peak gradient across the PV in mmhg preoperatively One week for preoperative assessment.
Primary PV annulus and PV z-score Parameters will be measured include median PV annulus diameter in mm , median PV Z-score diameter in mm preoperatively One week for preoperative assessment.
Primary degree of PV regurge, degree of TR and RV size Parameters will be measured include degree of PV regurge jet size by color doppler,degree of TR by jet area -central jets in cm^2 , RV size (RV diastolic area in cm^ , RV systolic area in cm^ ) preoperatively One week for preoperative assessment.
Primary Age Parameters will be measured include age in months preoperatively One week for preoperative assessment
Secondary Gender Parameters will be measured include gender pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary Body weight Parameters will be measured include body weight in kilograms pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary Height Parameters will be measured include height in meters pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary Oxygen saturation , RV function Parameters will be measured include Oxygen saturation level % , RV function by measure RV fractional area changes (RVFAC) % Pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary Median RVOT gradient and degree of PV stenosis Parameters will be measured include median RVOT gradient in mmhg , degree of PV stenosis by peak gradient across the PV in mmhg pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary PV annulus and PV z-score Parameters will be measured include median PV annulus diameter in mm , median PV Z-score diameter in mm pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary degree of PV regurge, degree of TR and RV size Parameters will be measured include degree of PV regurge jet size by color doppler,degree of TR by jet area -central jets in cm^2 , RV size (RV diastolic area in cm^ , RV systolic area in cm^ ) pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary Median cross clamp time and CPB time Parameters will be measured include Median cross clamp time in minutes and CPB time in minutes pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary ICU stay Parameters will be measured include ICU stay days pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary Time till weaning from mechanical ventilator Parameters will be measured include Time till weaning from mechanical ventilator in hours pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
Secondary Age Parameters will be measured include age in months pre-discharge postoperative assessment. Pre-discharge postoperative assessment within one month
See also
  Status Clinical Trial Phase
Recruiting NCT05077774 - Harmony TPV Post-Approval Study N/A
Recruiting NCT05452720 - MASA Valve Early Feasibility Study N/A
Active, not recruiting NCT02979587 - The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study N/A
Completed NCT00576381 - Understanding Dexmedetomidine in Neonates After Open Heart Surgery Phase 1